High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients
Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Neuwirtova, R, Siskova, M, Stopka, T, Lauermannova, M, Maaloufova, J. Soukupova, Salek, C, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Jonasova, A
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels
Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Jonasova, A, Myslivcova, D, Siskova, M, Stopka, T, Lauermannova, M, Salek, C, Maaloufova, J. Soukupova, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Neuwirtova, R
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA
Fuchs, O, Polak, J, Bokorova, R, Vostry, M, Kostecka, A, Hajkova, H, Neuwirtova, R, Siskova, M, Cermak, J, Sponerova, D, Lauermannova, M, Soukupova, J, Cervinek, L, Brezinova, J, Michalova, K, Jonasova, A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P24 - Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: MUTATIONS IN RUNX1 GENE CONTRIBUTE TO THE PROGRESSION OF LOWER-RISK MDS PATIENTS BY DISRUPTING CELLULAR PROTECTION AGAINST MALIGNANT TRANSFORMATION
Kaisrlikova, M., Vesela, J., Vostry, M., Votavova, H., Kundrat, D., Merkerova, M. Dostalova, Lauermannova, M., Maaloufova, J. Soukupova, Zemanova, Z., Jonasova, A., Cermak, J., Belickova, M.
Published in Leukemia research (01.09.2021)
Published in Leukemia research (01.09.2021)
Get full text
Journal Article
Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling
Kaisrlikova, M., Vesela, J., Vostry, M., Votavova, H., Kundrat, D., Merkerova, M. Dostalova, Lauermannova, M., Maaloufova, J. Soukupova, Zemanova, Z., Jonasova, A., Cermak, J., Belickova, M.
Published in Leukemia research (01.09.2021)
Published in Leukemia research (01.09.2021)
Get full text
Journal Article
227 - High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients
Fuchs, O., Polak, J., Bokorova, R., Kostecka, A., Vostry, M., Neuwirtova, R., Siskova, M., Stopka, T., Lauermannova, M., Maaloufova, J. Soukupova, Salek, C., Mikulenkova, D., Cermak, J., Brezinova, J., Zemanova, Z., Michalova, K., Jonasova, A.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
228 - MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels
Fuchs, O., Polak, J., Bokorova, R., Kostecka, A., Vostry, M., Jonasova, A., Myslivcova, D., Siskova, M., Stopka, T., Lauermannova, M., Salek, C., Maaloufova, J. Soukupova, Mikulenkova, D., Cermak, J., Brezinova, J., Zemanova, Z., Michalova, K., Neuwirtova, R.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article